Last reviewed · How we verify
FT-1101
At a glance
| Generic name | FT-1101 |
|---|---|
| Also known as | FT1101 |
| Sponsor | Forma Therapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FT-1101 CI brief — competitive landscape report
- FT-1101 updates RSS · CI watch RSS
- Forma Therapeutics, Inc. portfolio CI